| 000 | 01769 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517004235.0 | ||
| 264 | 0 | _c20170904 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2014.10.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Xue-Feng | |
| 245 | 0 | 0 |
_aSuppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _c11 2014 |
||
| 300 |
_a146-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzofurans _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aColitis _xchemically induced |
| 650 | 0 | 4 |
_aDextran Sulfate _xtoxicity |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammasomes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNLR Family, Pyrin Domain-Containing 3 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aOuyang, Zi-Jun | |
| 700 | 1 | _aFeng, Li-Li | |
| 700 | 1 | _aChen, Gong | |
| 700 | 1 | _aGuo, Wen-Jie | |
| 700 | 1 | _aShen, Yan | |
| 700 | 1 | _aWu, Xu-Dong | |
| 700 | 1 | _aSun, Yang | |
| 700 | 1 | _aXu, Qiang | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 281 _gno. 1 _gp. 146-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2014.10.002 _zAvailable from publisher's website |
| 999 |
_c24403253 _d24403253 |
||